Skip to main content
Premium Trial:

Request an Annual Quote

Febit Integrates InforSense Technology into Microarray Platform

NEW YORK (GenomeWeb News) – Febit has integrated components of the InforSense visualization platform into its new Geniom microarray system, InforSense said today.

Under the agreement, Febit has embedded the InforSense platform, workflows and visualizations, into the Geniom instruments.

The InforSense platform provides data analytics and application development capabilities, and the VisualSense provides interactive, web-based visualization tools. The Geniom is used in target sequence capture before next-generation sequencing projects and in classical transcriptomics applications.

"Our applications require a platform with the ability to handle massive amounts of data, which can then be boiled down and presented in manageable size pieces to our end-users," explained Febit's VP of Global Informatics, Anthony Caruso, in a statement. "Developing on the InforSense platform has enabled us to focus on the bioinformatics and computational algorithms, which are core to our business."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.